Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W108
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 92,448,158
- Total 13F shares
- 9,927,525
- Share change
- +965,959
- Total reported value
- $150,401,616
- Price per share
- $15.15
- Number of holders
- 51
- Value change
- +$14,713,541
- Number of buys
- 22
- Number of sells
- 20
Quarterly Holders Quick Answers
What is CUSIP 92511W108?
CUSIP 92511W108 identifies VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92511W108:
Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.7%
|
3,410,412
|
$39,254,000 | — | 31 Dec 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.6%
|
1,479,733
|
$17,032,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.78%
|
718,892
|
$8,275,000 | — | 31 Dec 2020 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.72%
|
665,511
|
$7,660,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.64%
|
595,652
|
$6,856,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.36%
|
335,318
|
$3,860,000 | — | 31 Dec 2020 | |
| Fosun International Ltd |
13F
|
Company |
0.35%
|
324,061
|
$3,730,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.24%
|
223,178
|
$2,569,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
184,766
|
$2,126,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
177,868
|
$2,047,000 | — | 31 Dec 2020 | |
| FMR LLC |
13F
|
Company |
0.15%
|
136,949
|
$1,576,000 | — | 31 Dec 2020 | |
| SteelPeak Wealth, LLC |
13F
|
Company |
0.14%
|
132,961
|
$1,530,000 | — | 31 Dec 2020 | |
| Altium Capital Management LLC |
13F
|
Company |
0.12%
|
108,794
|
$1,252,000 | — | 31 Dec 2020 | |
| David M. Knott |
13F
|
Individual |
0.08%
|
76,585
|
$881,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
50,785
|
$584,000 | — | 31 Dec 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.05%
|
47,054
|
$542,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
31,632
|
$365,000 | — | 31 Dec 2020 | |
| MML INVESTORS SERVICES, LLC |
13F
|
Company |
0.03%
|
26,575
|
$306,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
25,200
|
$290,000 | — | 31 Dec 2020 | |
| Creative Planning |
13F
|
Company |
0.02%
|
20,000
|
$230,000 | — | 31 Dec 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
19,472
|
$224,000 | — | 31 Dec 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
17,700
|
$204,000 | — | 31 Dec 2020 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.02%
|
17,300
|
$199,000 | — | 31 Dec 2020 | |
| Capital Investment Advisory Services, LLC |
13F
|
Company |
0.02%
|
15,125
|
$174,000 | — | 31 Dec 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
14,094
|
$162,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
13,666
|
$157,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
13,520
|
$155,000 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
13,199
|
$152,000 | — | 31 Dec 2020 | |
| BECK MACK & OLIVER LLC |
13F
|
Company |
0.01%
|
10,000
|
$115,000 | — | 31 Dec 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
9,063
|
$104,000 | — | 31 Dec 2020 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
7,231
|
$83,000 | — | 31 Dec 2020 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
6,107
|
$71,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
5,508
|
$63,000 | — | 31 Dec 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
4,819
|
$56,000 | — | 31 Dec 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
4,700
|
$54,000 | — | 31 Dec 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
4,015
|
$46,000 | — | 31 Dec 2020 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
2,827
|
$32,539 | — | 31 Dec 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
2,495
|
$29,000 | — | 31 Dec 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
1,881
|
$21,000 | — | 31 Dec 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,562
|
$18,000 | — | 31 Dec 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,400
|
$16,000 | — | 31 Dec 2020 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
1,080
|
$12,000 | — | 31 Dec 2020 | |
| STRS OHIO |
13F
|
Company |
0%
|
300
|
$3,000 | — | 31 Dec 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
162
|
$2,000 | — | 31 Dec 2020 |
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q1 2021
As of 31 Mar 2021,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,927,525 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, KORNITZER CAPITAL MANAGEMENT INC /KS, VANGUARD GROUP INC, BlackRock Inc., Altium Capital Management LP, Fosun International Ltd, FMR LLC, STATE STREET CORP, and Monashee Investment Management LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
44
Q1 2021 holders
51
Holder diff
7
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.